Lexicon Pharma (LXRX) Tops Q2 EPS by 3c
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $1.54 -3.75%
Financial Fact:
Consolidated net loss per common share, basic and diluted: -0.35
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Consolidated net loss per common share, basic and diluted: -0.35
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q2 EPS of ($0.13), $0.03 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $234 thousand, versus $9.16 million reported last year.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Data I/o Corp (DAIO) Misses Q2 EPS by 7c
- L3Harris Technologies (LHX) Tops Q1 EPS by 15c; raises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
